CALC

1.2607.69%
SH

Sudarshan Hebbar

Chief Medical Officer

Dr. Sudarshan Hebbar, M.D., has been Chief Medical Officer of CalciMedica, Inc. since April 2017. Dr. Hebbar served as the Senior Vice President of Clinical Development at CalciMedica, Inc. since from November 2015 to April 2017 and as a consultant from June 2014 to November 2015. Dr. Hebbar was a consultant for Mallinckrodt Pharmaceuticals, where he served as the clinical development lead for a global multicenter Phase IV trial. Prior to that, he served as Vice President of Nephrology at Thrasos Innovation where he helped implement a global multicenter Phase II trial of a novel therapeutic compound for acute kidney injury. Before working at Thrasos, Dr. Hebbar served as Medical V.P. and a member of the U.S. Board of Directors at Oncimmune, as a medical director at Reata Pharmaceuticals and as a senior medical director in the Quality and Regulatory division at Abbott and then lead of a medical team supporting research and commercialization in the Diagnostics division at Abbott. Dr. Hebbar was in private practice before joining industry, focused on nephrology, transplant and critical care medicine. He received a B.A. in Natural Sciences from The Johns Hopkins University and a M.D. from Tulane University School of Medicine. He completed a residency in Internal Medicine and a fellowship in Critical Care Medicine, both at Hennepin County Medical Center, a fellowship in Nephrology at the University of Chicago and a fellowship in Clinical Medical Ethics at The Maclean Center for Clinical Medical Ethics at the University of Chicago.

公司职务